Author:
Toure Offianan Andre,Valecha Neena,Tshefu Antoinette K.,Thompson Ricardo,Krudsood Srivicha,Gaye Oumar,Rao Bappanaidu Hoigegudde Krishnamurthy,Sagara Issaka,Bose Tarit Kumar,Mohanty Sanjib,Rao Ballamudi Srinivas,Anvikar Anupkumar R.,Mwapasa Victor,Noedl Harald,Arora Sudershan,Roy Arjun,Iyer Sunil S.,Sharma Pradeep,Saha Nilanjan,Jalali Rajinder K.
Funder
National Institute of Health
Sun Pharmaceutical Industries Limited
erstwhile Ranbaxy Laboratories Ltd
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Reference23 articles.
1. WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010. Geneva, Switzerland: World Health Organization, 2010.
2. WHO. Guidelines for the Treatment of Malaria. Geneva, Switzerland: World Health Organization, 2010.
3. Malaria control beyond 2010
4. Demand for malaria drug soars
5. Arterolane, a New Synthetic Trioxolane for Treatment of UncomplicatedPlasmodium falciparumMalaria: A Phase II, Multicenter, Randomized, Dose‐Finding Clinical Trial
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献